tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RARE Stock Latest News

Optimistic Outlook for Ultragenyx Pharmaceutical Amid Promising Gene Therapy Developments
RatingsOptimistic Outlook for Ultragenyx Pharmaceutical Amid Promising Gene Therapy Developments
3d ago
RARE
Ultragenyx’s BLA for UX111 accepted by FDA for priority review
PremiumThe Fly
Ultragenyx’s BLA for UX111 accepted by FDA for priority review
3d ago
RARE
Ultragenyx price target raised to $136 from $121 at Canaccord
PremiumThe Fly
Ultragenyx price target raised to $136 from $121 at Canaccord
3d ago
RARE
3 Best Stocks to Buy Now, 2/18/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 2/18/2025, According to Top Analysts
3d ago
HL
RARE
Ultragenyx Pharmaceutical: Strong Growth Prospects and Pipeline Advancements Reinforce Buy Rating
PremiumRatings
Ultragenyx Pharmaceutical: Strong Growth Prospects and Pipeline Advancements Reinforce Buy Rating
4d ago
RARE
Ultragenyx Reports Strong Growth Amid Challenges
PremiumCompany AnnouncementsUltragenyx Reports Strong Growth Amid Challenges
5d ago
RARE
Ultragenyx price target raised to $86 from $73 at TD Cowen
Premium
The Fly
Ultragenyx price target raised to $86 from $73 at TD Cowen
7d ago
RARE
Ultragenyx Pharmaceutical: Promising Growth Prospects with Strong Financial Outlook and Key Pipeline Developments
Premium
Ratings
Ultragenyx Pharmaceutical: Promising Growth Prospects with Strong Financial Outlook and Key Pipeline Developments
7d ago
RARE
Promising Developments in Ultragenyx Pharmaceuticals Drive Ed Arce’s Buy Rating
PremiumRatings
Promising Developments in Ultragenyx Pharmaceuticals Drive Ed Arce’s Buy Rating
7d ago
RARE
Ultragenyx Pharmaceutical Reports Strong 2024 Growth
PremiumCompany Announcements
Ultragenyx Pharmaceutical Reports Strong 2024 Growth
7d ago
RARE
Ultragenyx Pharmaceutical’s Strong Sales and Promising Pipeline Support Buy Rating
PremiumRatings
Ultragenyx Pharmaceutical’s Strong Sales and Promising Pipeline Support Buy Rating
7d ago
RARE
Ultragenyx reports Q4 EPS ($1.39), consensus ($1.27)
PremiumThe Fly
Ultragenyx reports Q4 EPS ($1.39), consensus ($1.27)
8d ago
RARE
Ultragenyx sees FY25 revenue $640M-$670M, consensus $651.93M
PremiumThe FlyUltragenyx sees FY25 revenue $640M-$670M, consensus $651.93M
8d ago
RARE
RARE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RARE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
10d ago
RARE
Ultragenyx Pharmaceuticals: Buy Rating Supported by Promising Gene Therapy Trial Results and Regulatory Advancements
Premium
Ratings
Ultragenyx Pharmaceuticals: Buy Rating Supported by Promising Gene Therapy Trial Results and Regulatory Advancements
14d ago
RARE
Ultragenyx Pharmaceutical’s UX111 Poised for Success: Buy Recommendation Backed by Promising Clinical Data and Strong Pipeline
PremiumRatings
Ultragenyx Pharmaceutical’s UX111 Poised for Success: Buy Recommendation Backed by Promising Clinical Data and Strong Pipeline
15d ago
RARE
Ultragenyx announces new data on UX111 AV gene therapy
PremiumThe Fly
Ultragenyx announces new data on UX111 AV gene therapy
16d ago
RARE
Top 3 Trending Stocks, According to Analysts – 1/15/2025
PremiumMarket News
Top 3 Trending Stocks, According to Analysts – 1/15/2025
1M ago
DAL
STZ
Ultragenyx price target raised to $140 from $135 at Piper Sandler
PremiumThe Fly
Ultragenyx price target raised to $140 from $135 at Piper Sandler
1M ago
RARE
Ultragenyx: 1st patient dosed in Aspire studyof GTX-102 for Angelman treatment
PremiumThe FlyUltragenyx: 1st patient dosed in Aspire studyof GTX-102 for Angelman treatment
2M ago
RARE
Ultragenyx submits BLA to FDA for UX111
Premium
The Fly
Ultragenyx submits BLA to FDA for UX111
2M ago
RARE
Ultragenyx price target lowered to $102 from $105 at JPMorgan
Premium
The Fly
Ultragenyx price target lowered to $102 from $105 at JPMorgan
3M ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >